These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28017230)

  • 1. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
    J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Pappatà S; Santangelo G; Aarsland D; Vicidomini C; Longo K; Bronnick K; Amboni M; Erro R; Vitale C; Caprio MG; Pellecchia MT; Brunetti A; De Michele G; Salvatore M; Barone P
    Neurology; 2011 Oct; 77(14):1357-62. PubMed ID: 21940621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
    PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
    Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
    J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
    Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
    J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
    Liepelt I; Reimold M; Maetzler W; Godau J; Reischl G; Gaenslen A; Herbst H; Berg D
    Mov Disord; 2009 Jul; 24(10):1504-11. PubMed ID: 19489069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
    Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
    Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
    Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.
    Caviness JN; Hentz JG; Evidente VG; Driver-Dunckley E; Samanta J; Mahant P; Connor DJ; Sabbagh MN; Shill HA; Adler CH
    Parkinsonism Relat Disord; 2007 Aug; 13(6):348-54. PubMed ID: 17347022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.